Skip to main content

What the FDA labels say about taking them together

Itraconazole and vamorolone

Vamorolone's FDA label of January 22, 2026 names itraconazole in its drug interactions section; the itraconazole labels PlainMeds reads (2) do not name vamorolone. The vamorolone label: “Drugs on Vamorolone Co-administration of AGAMREE with itraconazole, a strong CYP3A4 inhibitor, increases vamorolone exposure.”

Check it at the source: the itraconazole FDA label on DailyMed (effective July 13, 2026, Janssen Pharmaceuticals, Inc.); the vamorolone FDA label on DailyMed (effective January 22, 2026, Catalyst Pharmaceuticals, Inc.).

What does the itraconazole label say about vamorolone?

Itraconazole's label (effective July 13, 2026) and its 1 other brand-application label do not name vamorolone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SPORANOX), Janssen Pharmaceuticals, Inc., effective July 13, 2026 (SPL set a4d555fa-787c-40fb-bb7d-b0d4f7318fd0), via openFDA; the full label on DailyMed

What does the vamorolone label say about itraconazole?

Vamorolone label, drug interactions

Drugs on Vamorolone Co-administration of AGAMREE with itraconazole, a strong CYP3A4 inhibitor, increases vamorolone exposure [see Clinical Pharmacology ( 12.3 )].

Source: FDA drug label (AGAMREE), Catalyst Pharmaceuticals, Inc., effective January 22, 2026 (SPL set fb376f09-cf9c-42b5-b4dd-02d5bcd73211), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Itraconazole generic labelers
0Vamorolone generic labelers
ItraconazoleVamorolone
Labeled forFungal infectionsn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.910 per capsule 100 mg capsulen/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?